Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring imatinib trough levels in newly diagnosed chronic phase CML
2010-019568-35Phase 2Active
- Sponsor
- Centre Hospitalier de Versailles
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of imatinib in chronic myeloid leukemia (CML) (2 arms), sponsored by Centre Hospitalier de Versailles. Primary endpoint: Major molecular response rate at 12 months in cohort 1. Started May 2010; status: active.
02
Drugs
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on 2010-019568-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019568-35.